Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
13.78
-0.41 (-2.89%)
At close: Oct 7, 2025, 4:00 PM EDT
13.78
0.00 (0.00%)
Pre-market: Oct 8, 2025, 4:01 AM EDT
Embecta Market Cap
Embecta has a market cap or net worth of $805.92 million as of October 8, 2025. Its market cap has decreased by -11.09% in one year.
Market Cap
805.92M
Enterprise Value
2.09B
1-Year Change
-11.09%
Ranking
Category
Stock Price
$13.78
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $805.92M, a decrease of -69.88%. That is a compound annual growth rate of -28.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 829.90M | -30.87% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |